Iktos

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Aqemia

This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.

Duplicat

This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.

Iambic Therapeutics

This company develops artificial intelligence platforms for drug discovery and clinical-stage therapeutics for biopharmaceutical partners and healthcare sectors.

Inductive Bio

This company provides a machine learning platform for compound optimization and ADMET prediction to biopharma and drug discovery organisations.

Variartional

This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.

Genesis Molecular AI

The company develops an artificial intelligence platform for molecular drug discovery to assist pharmaceutical firms in designing and optimising small molecule medicines.